CRISPR Therapeutics AG\uff08NASDAQ:CRSP\uff09<\/a>\u7684\u9577\u671f\u6295\u8cc7\u50f9\u503c\u53ef\u80fd\u66f4\u5927\u3002\u9019\u53ea\u57fa\u56e0\u7de8\u8f2f\u80a1\u7968\u7684\u50f9\u683c\u4eca\u5e74\u4e0a\u6f32\u8d85\u904e17%\uff0c\u4f46\u904e\u53bb12\u500b\u6708\u4f9d\u7136\u4e0b\u8dcc\u8d85\u904e20%\u3002<\/p>\nCRISPR\u80a1\u7968\u70ba\u4ec0\u9ebc\u9069\u5408\u9577\u7dda\u6295\u8cc7\uff1f\u6709\u4ee5\u4e0b3\u500b\u7406\u7531\uff1a<\/p>\n
1. exa-cel\u4e00\u65e6\u7372\u6279\uff0cCRISPR\u4e5f\u5c07\u53d7\u76ca<\/h2>\n
\u9019\u4e00\u57fa\u56e0\u7de8\u8f2f\u7642\u6cd5\u5982\u679c\u7372\u5f97\u6279\u51c6\uff0cCRISPR\u5c07\u7372\u5f9740%\u7684\u6536\u5165\u5206\u6210\uff0c\u9019\u53cd\u904e\u4f86\u53ef\u4ee5\u70ba\u9019\u5bb6\u81e8\u5e8a\u968e\u6bb5\u7684\u751f\u7269\u79d1\u6280\u516c\u53f8\u5176\u4ed6\u5728\u7814\u85e5\u7269\u7684\u958b\u767c\u63d0\u4f9b\u8cc7\u91d1\u652f\u6301\u3002\u53bb\u5e7412\u6708\uff0cExa-cel\u5728\u6b50\u76df\u548c\u82f1\u570b\u7684\u7533\u8acb\u7372\u5f97\u78ba\u8a8d\uff0c\u798f\u6cf0\u88fd\u85e5\u548cCRISPR\u9810\u8a08\u7f8e\u570b\u7684\u751f\u7269\u88fd\u5291\u8a31\u53ef\u7533\u8acb\uff08BLA\uff09\u5c07\u5728\u9019\u500b\u5b63\u5ea6\u5b8c\u6210\u3002<\/p>\n
\u6211\u5011\u4e0d\u80fd\u4fdd\u8b49FDA\u4e00\u5b9a\u6703\u6279\u51c6exa-cel\uff0c\u4f46\u8a72\u57fa\u56e0\u7de8\u8f2f\u7642\u6cd5\u7684\u4e09\u671f\u8a66\u9a57\u2014\u2014\u6cbb\u7642SCD\u7684CLIMB-121\u7814\u7a76\u4ee5\u53ca\u6cbb\u7642TDT\u7684CLIMB-111\u7814\u7a76\u2014\u2014\u7684\u7d50\u679c\u90fd\u975e\u5e38\u4e0d\u932f\u3002\u5b98\u65b9\u6578\u64da\u986f\u793a\uff0c\u7f8e\u570bTDT\u548cSCD\u7684\u60a3\u8005\u4eba\u6578\u5206\u5225\u4e0d\u52305000\u4eba\u548c\u5927\u7d0410\u842c\u4eba\uff0c\u4f46exa-cel\u7684\u5b9a\u50f9\u6216\u5c0d\u6a19Bluebird bio Inc\uff08NASDAQ:BLUE\uff09\u7684TDT\u57fa\u56e0\u7642\u6cd5Zynteglo\uff08$280\u842c\uff09\uff0c\u96d6\u7136\u6602\u8cb4\u4f46\u6709\u7372\u5229\u6f5b\u529b\uff0c\u56e0\u6b64\u4fdd\u96aa\u516c\u53f8\u53ef\u80fd\u9858\u610f\u627f\u4fdd\u3002<\/p>\n
2. CRISPR\u7684\u5176\u4ed6\u5728\u7814\u85e5\u7269\u524d\u666f\u53ef\u671f<\/h2>\n
CRISPR\u64c1\u670922\u500b\u5728\u7814\u85e5\u7269\uff0c\u96d6\u7136\u958b\u767c\u9032\u5ea6\u90fd\u4e0d\u53caexa-cel\uff0c\u4f46\u6709\u4e9b\u5df2\u7d93\u5728\u521d\u671f\u8a66\u9a57\u4e2d\u5c55\u73fe\u51fa\u6f5b\u529b\u3002\u6bd4\u5982\u8aaa\uff0c\u63a1\u7528\u540c\u7a2e\u7570\u9ad4CRISPR\/Cas9\u57fa\u56e0\u7de8\u8f2fCAR-T\u7d30\u80de\u7de8\u8f2f\u7684CTX110\u548cCTX130\u5747\u5be6\u73fe\u4e86\u6982\u5ff5\u9a57\u8b49\u3002CTX110\u6b63\u8655\u65bc\u6cbb\u7642CD19+B\u7d30\u80de\u60e1\u6027\u816b\u7624\u7684\u4e8c\u671f\u8a66\u9a57\uff0cCTX130\u6cbb\u7642\u5be6\u9ad4\u7624\u548c\u8840\u6db2\u75c5\uff0c\u4ee5CD70\u86cb\u767d\u8cea\u70ba\u9776\u9ede\u7684\u4e00\u671fCOBALT-LYM\u8a66\u9a57\u7d50\u679c\u7a4d\u6975\uff0c\u56e0\u6b64\u9084\u7372\u5f97\u4e86FDA\u7684\u518d\u751f\u91ab\u5b78\u5148\u9032\u7642\u6cd5\u8a8d\u5b9a\u3002\u6b64\u5916\uff0c\u8a72\u516c\u53f8\u9084\u806f\u624bViaCyte\u958b\u767c\u6cbb\u7642\u4e00\u578b\u7cd6\u5c3f\u75c5\u7684VCTX-210\uff0c\u4e26\u4e14\u525b\u525b\u5b8c\u6210\u4e86\u4e00\u671f\u8a66\u9a57\u7684\u7d66\u85e5\u3002<\/p>\n
3. \u6c92\u6709\u8b77\u57ce\u6cb3\u4f46\u5145\u6eff\u4e86\u53ef\u80fd\u6027<\/h2>\n
CRISPR Therapeutics\u4e26\u4e0d\u662f\u552f\u4e00\u7684CRISPR\u57fa\u56e0\u7de8\u8f2f\u516c\u53f8\uff0c\u56e0\u6b64\u4e26\u6c92\u6709\u7d50\u69cb\u4e0a\u7684\u8b77\u57ce\u6cb3\u3002\u4e0d\u904e\uff0c\u5b83\u7684CRISPR-Cas9\u7de8\u8f2f\u6280\u8853\u5c0d\u65bc\u55ae\u7d30\u80de\u7a81\u8b8a\u7684\u57fa\u56e0\u75be\u75c5\u5f88\u6709\u6548\uff0c\u800c\u9019\u985e\u75be\u75c5\u81f3\u5c11\u67091\u842c\u7a2e\uff0c\u6bd4\u5982\u8aaa\u56ca\u6027\u7e96\u7dad\u5316\u3001\u8840\u53cb\u75c5\u3001\u808c\u71df\u990a\u4e0d\u826f\u75c7\u4ee5\u53ca\u4ea8\u5ef7\u9813\u6c0f\u821e\u8e48\u75c5\u7b49\u3002\u622a\u81f312\u670831\u65e5\uff0c\u8a72\u516c\u53f8\u5831\u544a\u73fe\u91d1\u53ca\u73fe\u91d1\u7b49\u50f9\u7269$18.7\u5104\uff0c2022\u5e74\u6c92\u6709\u6536\u5165\uff0c\u8667\u640d$6.502\u5104\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"
CRISPR Therapeutics\u7684\u80a1\u7968\u73fe\u5728\u9084\u4fbf\u5b9c\uff0c\u4f46\u4e0d\u6703\u6c38\u9060\u4fbf\u5b9c\u4e0b\u53bb \u904e\u53bb12\u500b\u6708\uff0c\u7f8e\u80a1\u5f88\u591a\u57fa\u56e0\u7de8\u8f2f\u751f\u7269 […]<\/p>\n","protected":false},"author":27,"featured_media":450660,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1522,431],"tags":[809,927,563,564],"class_list":["post-454193","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1522","category-trends-strategies-zh-hant","tag-809","tag-927","tag--zh-hant","tag-564","sectors-life-science-zh-hant","locations-us-zh-hant","exchange-nasdaq-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/454193","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=454193"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/454193\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/450660"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=454193"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=454193"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=454193"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}